Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France

Emerg Infect Dis. 2023 Sep;29(9):1877-1881. doi: 10.3201/eid2909.230390.

Abstract

Cefiderocol resistance is increasingly reported in New Delhi metallo-β-lactamase-producing Enterobacterales. Genomic and phenotypic analysis of Escherichia coli sequence type 361, a primary clone causing carbapenemase spread in France, revealed mutations leading to cefiderocol resistance. Continued genomic surveillance of carbapenem-resistant Enterobacterales could clarify prevalence of cefiderocol-resistant E. coli in Europe.

Keywords: Enterobacterales; Escherichia coli; France; antimicrobial resistance; bacteria; carbapenemase; cefiderocol; enteric infections; epidemiology; food safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cefiderocol
  • Cephalosporins / pharmacology
  • Escherichia coli* / genetics
  • Europe
  • France / epidemiology
  • Gammaproteobacteria*

Substances

  • Cephalosporins